HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuanzhi Wang Selected Research

Neoplasms (Cancer)

1/2024Vascularization ability of glioma stem cells in different three-dimensional microenvironments.
7/2022Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics.
1/2022Alkoxy cyanoacrylate-based nanoparticles with stealth and brain-targeting properties.
10/2021Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy.
1/2021Coaxially Bioprinted Cell-Laden Tubular-Like Structure for Studying Glioma Angiogenesis.
11/2018Coaxial extrusion bioprinted shell-core hydrogel microfibers mimic glioma microenvironment and enhance the drug resistance of cancer cells.
11/2018Bioprinting of glioma stem cells improves their endotheliogenic potential.
1/2018Enrichment of glioma stem cell-like cells on 3D porous scaffolds composed of different extracellular matrix.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuanzhi Wang Research Topics

Disease

8Neoplasms (Cancer)
01/2024 - 01/2018
7Glioma (Gliomas)
01/2024 - 01/2018
1Periodontitis
07/2023
1Cardiovascular Diseases (Cardiovascular Disease)
07/2023
1Inflammation (Inflammations)
07/2023
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Diabetes Mellitus
01/2023
1Trigeminal Neuralgia (Tic Douloureux)
10/2022
1Nervous System Diseases (Neurological Disorders)
10/2022
1Pituitary Neoplasms (Pituitary Adenoma)
07/2022
1Brain Diseases (Brain Disorder)
01/2022
1Spinal Cord Injuries (Spinal Cord Injury)
03/2020
1Lung Neoplasms (Lung Cancer)
12/2018
1Wounds and Injuries (Trauma)
04/2006

Drug/Important Bio-Agent (IBA)

6HydrogelsIBA
01/2024 - 11/2018
2SuspensionsIBA
12/2018 - 11/2018
1Vitamin DFDA LinkGeneric
07/2023
1Plasminogen Activator Inhibitor 1IBA
01/2023
1Plasminogen Activators (Plasminogen Activator)IBA
01/2023
1Uric Acid (Urate)IBA
10/2022
1AntioxidantsIBA
10/2022
1Transcription Factors (Transcription Factor)IBA
07/2022
1Hormones (Hormone)IBA
07/2022
1Indicators and Reagents (Reagents)IBA
07/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1Antisense OligonucleotidesIBA
01/2022
1polydopamineIBA
10/2021
1Contrast MediaIBA
10/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021
1Mannose (D-Mannose)IBA
10/2021
1MetalsIBA
10/2021
1Silicon Dioxide (Silica)FDA LinkGeneric
10/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Green Fluorescent ProteinsIBA
01/2021
1GelatinIBA
12/2018
1AlginatesIBA
12/2018
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
11/2018
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2018
1Alkylating AgentsIBA
11/2018
1MethyltransferasesIBA
11/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1ChitosanIBA
01/2018
1Hyaluronic Acid (Hyaluronan)IBA
01/2018
1Adenosine Triphosphate (ATP)IBA
04/2006

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2022 - 10/2021
2Therapeutics
10/2021 - 01/2018
1Photothermal Therapy
10/2021
1Play Therapy (Therapy, Play)
03/2020